Smith & Nephew Up 9.3% On Takeover Talk (SNN, JNJ)

Shares of Smith & Nephew plc SNN are currently up 9.3% at $55.58 per share during Monday afternoon trading. The stock has been climbing since it was reported that Johnson & Johnson JNJ made a takeover offer for the company, which Smith & Nephew plc reportedly rejected. Today's trading range for shares of Smith & Nephew plc has been between $55.23 and a 52-week high of $56.80 per share. The consensus price target of analysts covering the company's stock is $48.50 per share. Volume of 1.7 million shares is far above the daily average volume of 105,000 shares. Smith & Nephew plc (SNN) is a global medical technology business, specializing in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies; Endoscopy and Advanced Wound Management. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies. Read more from Benzinga's Company news.